![Robert Arch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Arch
Präsident bei
Immunophotonics, Inc.
Profil
Robert H.
Arch currently works at Immunophotonics, Inc., as President from 2025.
Dr. Arch also formerly worked at OncoSec Medical, Inc., as President, CEO & Non-Independent Director from 2022 to 2023, Elpiscience Biopharma Ltd., as Head-Research from 2019 to 2021, and China Novartis Institutes for BioMedical Research Co., Ltd., as Head-Liver Disease Department from 2017 to 2019.
Dr. Arch received his doctorate degree from Julius-Maximilians-Universität Würzburg.
Aktive Positionen von Robert Arch
| Unternehmen | Position | Beginn |
|---|---|---|
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Präsident | 22.09.2025 |
Ehemalige bekannte Positionen von Robert Arch
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Vorstandsvorsitzender | 14.06.2023 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2021 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01.10.2019 |
Ausbildung von Robert Arch
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Health Technology |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. |
